Bio-Reference Laboratories, Inc. (NASDAQ:BRLI)

CAPS Rating: 4 out of 5

An independent clinical laboratory servicing the New York metropolitan area that offers a comprehensive list of laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring and treatment of diseases.

Recs

0
Player Avatar BuffetsMentor (< 20) Submitted: 4/7/2010 9:53:59 PM : Outperform Start Price: $22.02 BRLI Score: -19.47

stock split, and healthcare

Featured Broker Partners


Advertisement